Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents

International Journal of Obesity

Volumn 25, Issue 5, 2001, Pages 705-713

  Saleh, J ^a   Blevins, J E ^b   Havel, P J ^b   Barrett, J A ^b   Gietzen, D W ^b   Cianflone, K ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acylation stimulating protein; Adipose tissue; Complement C3a; Glucose; Non esterified fatty acid; Triglyceride

Indexed keywords

ACYLATION STIMULATING PROTEIN; COMPLEMENT COMPONENT C3A; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HYPERLIPIDEMIA; NONHUMAN; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AREA UNDER CURVE; BLOOD PROTEINS; COMPLEMENT C3A; CROSS-OVER STUDIES; EATING; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; LIPIDS; MALE; MICE; MICE, INBRED C57BL; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRIGLYCERIDES;

ANIMALIA; RODENTIA;

EID: 0035011251     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801613     Document Type: Article

References (60)

1. Metabolic and hormonal controls of food intake: Highlights of the last 25 years - 1972-1997
2. Strategies and potential molecular targets for obesity treatment
3. Control of food intake
4. Regulation of plasma fatty acid metabolism
5. Insulin and the central regulation of energy balance: Update 1994
6. Central nervous system control of food intake
7. Insulin in the brain: A hormonal regulator of energy balance
8. Role of brain insulin receptor in control of body weight and reproduction
9. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period
10. Role of adipose tissue in body-weight regulation: Mechanisms regulating leptin production and energy balance
11. Novel form of lipolysis induced by leptin
12. In vitro lipolytic effect of leptin on mouse adipocytes: Evidence for a possible autocrine/paracrine role of leptin
13. Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes
14. Intrinsic site-specific differences in the expression of leptin in human adipocytes and its autocrine effects on glucose uptake
15. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
16. Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats
17. Leptin inhibits insulin binding in isolated rat adipocytes
18. Leptin does not affect adipocyte glucose metabolism: Studies in fresh and cultured adipocytes
19. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells
20. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes
21. Acylation stimulating protein (ASP), an adipocyte autocrine: New directions
22. Regional specificity, of ASP binding in human adipose tissue
23. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation stimulating protein and insulin
24. ASP stimulates glucose transport in cultured human adipocytes
25. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line
26. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations
27. The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers
28. Acute in vitro production of ASP in differentiated adipocytes
29. Chylomicron specific enhancement of Acylation Stimulating Protein (ASP) and precursor protein C3 production in differentiated human adipocytes
30. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57BI/6 mice
31. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance
32. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice
33. Genetic deficiency of Acylation Stimulating Protein (ASP/C3adesArg) does not cause hyperapobetalipoproteinemia in mice
34. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein
35. Complement biosynthesis in the central nervous system
36. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease
37. Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus
38. Multiple brain sites sensitive to feeding stimulation by opioid agonists: A cannula-mapping study
39. Leptin in the anterior piriform cortex affects food intake in rats
40. The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin
41. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
42. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes
43. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia
44. Structure and function of C3a anaphylatoxin
45. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin
46. Signal transduction pathway of acylation stimulating protein: Involvement of protein kinase C
47. Characterization of plasma lipids in genetically obese mice: The mutants obese, diabetes, fat, tubby, and lethal yellow
48. Obese and diabetes, two mutant genes causing diabetes - Obesity syndromes in mice
49. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
50. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog
51. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice
52. The influence of age on the development of hypertriglyceridaemia and hypercholesterolaemia in genetically diabetic mice
53. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100
54. Reduced adipsin expression in murine obesity: Effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine
55. Lipoprotein lipase. Mechanism of product inhibition
56. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II
57. Release of endothelial lipoprotein lipase by plasma lipoproteins and free fatty acids
58. Lipoprotein lipase in plasma after an oral fat load: Relation to free fatty acids
59. Fatty acid control of lipoprotein lipase: A link between energy, metabolism and lipid transport